Molecular Characterization of Apocrine Salivary Duct Carcinoma
@article{Chiosea2015MolecularCO, title={Molecular Characterization of Apocrine Salivary Duct Carcinoma}, author={S. Chiosea and Lindsay D. Williams and Christopher C. Griffith and L. Thompson and I. Weinreb and J. Bauman and Alyssa Luvison and S. Roy and R. Seethala and M. Nikiforova}, journal={The American Journal of Surgical Pathology}, year={2015}, volume={39}, pages={744–752} }
Contemporary classification and treatment of salivary duct carcinoma (SDC) require its thorough molecular characterization. Thirty apocrine SDCs were analyzed by the Ion Ampliseq Cancer HotSpot panel v2 for mutations in 50 cancer-related genes. Mutational findings were corroborated by immunohistochemistry (eg, TP53, BRAF, &bgr;-catenin, estrogen, and androgen receptors) or Sanger sequencing/SNaPshot polymerase chain reaction. ERBB2 (HER2), PTEN, FGFR1, CDKN2A/P16, CMET, EGFR, MDM2, and PIK3CA… CONTINUE READING
Topics from this paper
55 Citations
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer
- Biology, Medicine
- Clinical Cancer Research
- 2016
- 86
- PDF
The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
- Biology, Medicine
- Human pathology
- 2019
- 8
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
- Biology, Medicine
- Oncotarget
- 2018
- 18
- PDF
Molecular patterns in salivary duct carcinoma identify prognostic subgroups
- Medicine
- Modern Pathology
- 2020
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
- Medicine
- Cancer medicine
- 2019
- 10
Biomarker Immunoprofile and molecular characteristics in salivary duct carcinoma: Clinicopathologic and prognostic implications.
- Medicine
- Human pathology
- 2019
- 3
Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland
- Biology, Medicine
- The American journal of surgical pathology
- 2018
- 36
Somatic mutations in salivary duct carcinoma and potential therapeutic targets.
- Medicine
- Oncotarget
- 2017
- 15
- Highly Influenced
- PDF
References
SHOWING 1-10 OF 53 REFERENCES
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
- Medicine
- Journal of Translational Medicine
- 2014
- 34
PIK3CA Mutations and PTEN Loss in Salivary Duct Carcinomas
- Biology, Medicine
- The American journal of surgical pathology
- 2013
- 46
p53 mutations and overexpression in locally advanced breast cancers.
- Biology, Medicine
- British Journal of Cancer
- 1994
- 77
- PDF
Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment
- Medicine
- Clinical Cancer Research
- 2012
- 89
- PDF
Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer
- Biology, Medicine
- British Journal of Cancer
- 2012
- 49
- PDF
PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma
- Biology, Medicine
- BMC Cancer
- 2013
- 47
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2013
- 53
Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma
- Medicine
- International Journal of Clinical Oncology
- 2014
- 65
Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
- Medicine
- Journal of neurosurgery
- 2006
- 141
An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions
- Biology, Medicine
- Histopathology
- 2013
- 43